MEG3 and neoplasm: Prognostic value: Lower MEG3 expression was associated with higher WHO grade, older age at the time of diagnosis, low Karnofsky performance score (KPS), isocitrate dehydrogenase (IDH) wild-type, tumor recurrence, and poor overall survival (72, 74, 76, 86).